SPAC Overview
Timeline Progress
About
Averin Capital Acquisition Corp. is a blank-check company seeking to combine with an unidentified business. Although it may pursue a target in any industry, it intends to capitalize on its management team's expertise at the intersection of technology and health, with an emphasis on operationally oriented acquisition opportunities.
Investment Focus
Technology, Healthcare
The terms and the filing trail behind Averin Capital Acquisition Corp.
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Leadership
Underwriters
Extended Team Information
Led by Chairman and CEO David A. Berry, a healthcare and technology entrepreneur, operator and investor with experience founding and building companies including Valo Health, and CFO and Secretary Alex Lau, an operations and finance leader at Averin Capital. The director nominees bring life-sciences advisory, finance, biotechnology and pharmaceutical operating experience.